Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

References

• BashROCristWMShusterJJClinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group studyBlood199381211078471769
   PubMed Web of Science ®Google Scholar
• BergSLBlaneySMDevidasMPhase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children’s Oncology GroupJ Clin Oncol20052333768215908649
   PubMed Web of Science ®Google Scholar
• ChessellsJMVeysPKempskiHLong-term follow-up of relapsed childhood acute lymphoblastic leukaemiaBr J Haematol200312339640514616997
   PubMed Web of Science ®Google Scholar
• CohenAGudasLJAmmannAJDeoxyguanosine triphos-phate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiencyJ Clin Invest1978611405996138
   PubMed Web of Science ®Google Scholar
• CohenALeeJWGelfandEWSelective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cellsBlood19836166066600944
   PubMed Web of Science ®Google Scholar
• CohenMHJohnsonJRMassieTApproval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphomaClin Cancer Res20061253293517000665
   PubMed Web of Science ®Google Scholar
• ConterVAricoMValsecchiMGLong-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982–1995Leukemia200014219620411187911
   PubMed Web of Science ®Google Scholar
• CristWMShusterJJFallettaJClinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group StudyBlood198872189173058229
   PubMed Web of Science ®Google Scholar
• DeAngeloDJYuDDodgeRKA Phase II study of 2-amino-9β-D-arabinosyl-6-methoxy-9H-purine(506U78) in patients with relapse or refractory T-lineage acute lymphoblastic leukemias (ALL) or lymphoblastic lymphoma (abstract): CALGB Study 19801Blood2002100742
   Web of Science ®Google Scholar
• DunsmoreKDevidasMBorowitzMJNelarabine can be safely incorporated into an intensive, multiagent chemotherapy regimen for the treatment of T-cell acute-lymphocytic leukemia (ALL) in children: A report of the Children’s Oncology Group (COG) AALL00P2 protocol for T-cell leukemiaBlood (ASH Annual Meeting Abstracts)20061081864
   Web of Science ®Google Scholar
• FairbanksLDTaddeoADuleyJAMechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiencyJ Immunol1990144485912104895
   PubMed Web of Science ®Google Scholar
• GandhiVMineishiSHuangPCytotoxicity, metabolism, and mechanisms of action of 2′, 2′-difluorodeoxyguanosine in Chinese hamster ovary cellsCancer Res1995551517247533664
   PubMed Web of Science ®Google Scholar
• GandhiVPlunkettWRodriquezCOCompound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseJ Clin Oncol1998163607159817282
   PubMed Web of Science ®Google Scholar
• GandhiVPlunkettWWellerSEvaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsJ Clin Oncol20011921425211304766
   PubMed Web of Science ®Google Scholar
• GarandRVannierJPBeneMCComparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d’Etude Immunologique des LeucemiesLeukemia19904739442232884
   PubMed Web of Science ®Google Scholar
• GaynonPSTriggMEHeeremaNAChildren’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995Leukemia20001422233311187913
   PubMed Web of Science ®Google Scholar
• GiblettERAmmannAJWaraDWNucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunityLancet197511010348676
   PubMed Web of Science ®Google Scholar
• GoekbugetNArnoldRAttaJCompound GW506U78 has high single-drug activity and good feasibility in heavily preatreated relapsed T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) and offers the option for cure with stem cell transplantation (SCT) [abstract]Blood2005106S1 Abstract 150
   Google Scholar
• GoyABleyerAHagemeisterFPhase II study of compound GW506U78 (araG) for patients with indolent B-cell or peripheral T-cell lymphoma previously treated with chemotherapyPresented at 45th Annual Meeting; American Society of Hematology2003
   Google Scholar
• GravattLCChaffeeSHebertMEEfficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia modelLeukemia19937126178350627
   PubMed Web of Science ®Google Scholar
• KisorDFPlunkettWKurtzbergJPharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignanciesJ Clin Oncol200018995100310694549
   PubMed Web of Science ®Google Scholar
• KurtzbergJErnstTJKeatingMJPhase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Clin Oncol200523339640315908652
   PubMed Web of Science ®Google Scholar
• LambeCUAverettDRPaffMT2-Amino-6-methoxy-purine arabinoside: an agent for T-cell malignanciesCancer Res199555335267614470
   PubMed Web of Science ®Google Scholar
• MitchellBSMejiasEDaddonaPEPurinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T-cellsProc Natl Acad Sci USA19787550114311004
   PubMed Web of Science ®Google Scholar
• MomparlerRLFisherGAMammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinosideJ Biol Chem196824342983045684726
   PubMed Web of Science ®Google Scholar
• OsborneWRScottCRThe metabolism of deoxyguanosine and guanosine in human B and T-lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiencyBiochem J198321471186312962
   PubMed Web of Science ®Google Scholar
• PrusKLAverettDRZimmermanTPTransport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influxCancer Res1990501817212306735
   PubMed Web of Science ®Google Scholar
• PuiCHEvansWEAcute lymphoblastic leukemiaN Engl J Med1998339605159718381
   PubMed Web of Science ®Google Scholar
• PuiCHRellingMVEvansWERole of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemiaBest Pract Res Clin Haematol2002157415612617874
   PubMed Web of Science ®Google Scholar
• PuiCHChengCLeungWExtended follow-up of long-term survivors of childhood acute lymphoblastic leukemiaN Engl J Med2003349640912917300
   PubMed Web of Science ®Google Scholar
• PuiCHRellingMVDowningJRAcute lymphoblastic leukemiaN Engl J Med200435015354815071128
   PubMed Web of Science ®Google Scholar
• ReiterASchrappeMLudwigWDChemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86Blood1994843122337949185
   PubMed Web of Science ®Google Scholar
• RodriquezCOLeghaJKEsteyEPharmacological and biochemical strategies to increase the accumulation of arabinofuranosyl-guanine triphosphate in primary human leukemia cellsClin Cancer Res199732107139815603
   PubMed Web of Science ®Google Scholar
• RodriguezCOGandhiVArabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary stepCancer Res19995949374310519407
   PubMed Web of Science ®Google Scholar
• RodriquezCOMitchellBSAyresMArabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinaseCancer Res2002623100512036920
   PubMed Web of Science ®Google Scholar
• RodriquezCOStellrechtCMGandhiVMechanisms for T-cell selective cytotoxicity of arabinosylguanineBlood20031021842812750168
   PubMed Web of Science ®Google Scholar
• SchorinMABlattnerSGelberRDTreatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children’s Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01J Clin Oncol19941274078151317
   PubMed Web of Science ®Google Scholar
• SmithMArthurDCamittaBUniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemiaJ Clin Oncol19961418248558195
   PubMed Web of Science ®Google Scholar
• UckunFMSenselMGSunLBiology and treatment of childhood T-lineage acute lymphoblastic leukemiaBlood199891735469446631
   PubMed Web of Science ®Google Scholar
• VidarssonBAbonourRWilliamsECFludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory, or poor prognosis acute leukemiaLeuk Lymphoma2001413213111378544
   PubMed Web of Science ®Google Scholar